ACCD Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 136548 min ago

@ $13.03

Išleistas: 14 vas. 2024 @ 22:30

Grąža: -42.59%

Ankstesnis signalas: vas. 13 - 22:53

Ankstesnis signalas: Pardavimas

Grąža: 2.93 %

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	534 344
Vidutinė apimtis	655 085
Rinkos kapitalizacija	586.11M
EPS	$0 ( 2024-04-25 )
Kita pelno data	( $-0.0700 ) 2024-06-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.62
ATR14	$0.0100 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-10	Hilton Michael W	Buy	183	Common Stock
2024-05-10	Hilton Michael W	Sell	183	Restricted Stock Units
2024-05-10	Barnes Stephen H.	Buy	770	Common Stock
2024-05-13	Barnes Stephen H.	Sell	214	Common Stock
2024-05-10	Barnes Stephen H.	Sell	770	Restricted Stock Units

INSIDER POWER
12.55
Last 100 transactions
Buy: 47 172 \| Sell: 35 993

Tūris Koreliacija

Ilgas: 0.55 (weak)

Trumpas: 0.85 (strong)

Signal:(84.618) Same movement expected

Accolade, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
CNTG	0.912
FXNC	0.91
SIRI	0.899
PEV	0.895
AKAN	0.894
FANH	0.889
EEIQ	0.889
LCFY	0.889
IMKTA	0.888
BPTH	0.887

10 Labiausiai neigiamai susiję koreliacijos
PRIM	-0.917
FRLA	-0.908
WING	-0.908
SFM	-0.901
WFRD	-0.899
FANG	-0.897
PNTG	-0.897
VCTR	-0.897
SHLD	-0.896
PPC	-0.893

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Accolade, Inc. Koreliacija - Valiuta/Žaliavos

-0.27
( neutral )

0.62
( weak )

0.00
( neutral )

0.67
( moderate )

-0.48
( neutral )

Accolade, Inc. Finansinės ataskaitos

Annual	2024
Pajamos:	$414.29M
Bruto pelnas:	$143.63M (34.67 %)
EPS:	$-1.330

FY	2024
Pajamos:	$414.29M
Bruto pelnas:	$143.63M (34.67 %)
EPS:	$-1.330

FY	2024
Pajamos:	$414.29M
Bruto pelnas:	$192.06M (46.36 %)
EPS:	$-0.00130

FY	2023
Pajamos:	$363.14M
Bruto pelnas:	$164.24M (45.23 %)
EPS:	$-6.45

Financial Reports:

No articles found.

Accolade, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Accolade, Inc.

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.